Literature DB >> 14044011

CONVERSION OF THE PHASE I ANTIGEN OF COXIELLA BURNETII TO HAPTEN BY PHENOL TREATMENT.

R L ANACKER, W T HASKINS, D B LACKMAN, E RIBI, E G PICKENS.   

Abstract

Anacker, R. L. (Rocky Mountain Laboratory, Hamilton, Mont.), W. T. Haskins, D. B. Lackman, E. Ribi, and E. G. Pickens. Conversion of the phase I antigen of Coxiella burnetii to hapten by phenol treatment. J. Bacteriol. 85:1165-1170. 1963.-Trichloroacetic acid extracts of Coxiella burnetii are converted to hapten by treatment with phenol. Such extracts react, like the original trichloroacetic acid extract, at high dilution in the complement-fixation test and produce zones of precipitate with specific antibody in gel diffusion tests; but, unlike the parent extract, injection of the phenol-treated extract neither induces resistance to challenge in guinea pigs nor antibody formation in guinea pigs, rabbits, or mice. This loss of antigenicity is correlated with removal of protein from the original product.

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; COMPLEMENT FIXATION TESTS; COXIELLA; EXPERIMENTAL LAB STUDY; GUINEA PIGS; MICE; PHENOLS; POLYSACCHARIDES, BACTERIAL; PRECIPITIN TESTS; RABBITS; TRICHLOROACETIC ACID

Mesh:

Substances:

Year:  1963        PMID: 14044011      PMCID: PMC278300          DOI: 10.1128/jb.85.5.1165-1170.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Identification of Rickettsia rickettsii in the wood tick, Dermacentor andersoni, by means of fluorescent antibody.

Authors:  W BURGDORFER; D LACKMAN
Journal:  J Infect Dis       Date:  1960 Sep-Oct       Impact factor: 5.226

2.  Preparation and properties of an aluminum citrate-endotoxin complex from Salmonella enteritidis.

Authors:  W T HASKINS; E RIBI; M LANDY; R L ANACKER; K C MILNER
Journal:  Proc Soc Exp Biol Med       Date:  1963-01

3.  New color reactions for determination of sugars in polysaccharides.

Authors:  Z DISCHE
Journal:  Methods Biochem Anal       Date:  1955

4.  The determination of phosphorus and phosphatase with N-phenyl-p-phenylenediamine.

Authors:  R L DRYER; A R TAMMES; J I ROUTH
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

5.  Intradermal sensitivity testing in man with a purified vaccine for Q fever.

Authors:  D B LACKMAN; E J BELL; J F BELL; E G PICKENS
Journal:  Am J Public Health Nations Health       Date:  1962-01

6.  Q fever in California. I. Observations on vaccination of human beings.

Authors:  G MEIKLEJOHN; E H LENNETTE
Journal:  Am J Hyg       Date:  1950-07
  6 in total
  10 in total

1.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Identification of phase-specific antigenic fractions of Coxiella burnetti by enzyme-linked immunosorbent assay.

Authors:  J C Williams; L A Thomas; M G Peacock
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

3.  Partial chemical characterization of a toxic lipopolysaccharide from Coxiella burneti.

Authors:  O G Baca; D Paretsky
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

Review 4.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation.

Authors:  T R Jerrells; L P Mallavia; D J Hinrichs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Immunological properties of Rickettsia rickettsii purified by zonal centrifugation.

Authors:  R L Anacker; R K Gerloff; L A Thomas; R E Mann; W D Bickel
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.

Authors:  M S Ascher; J C Williams; M A Berman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

8.  Passive cutaneous anaphylaxis with antigens from Coxiella burneti.

Authors:  M Peacock; J Munoz; G L Tallent; R A Ormsbee
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

9.  Electron-microscopic study of the effect of various extractants on the morphology of Coxiella burnetii.

Authors:  M Vavreková; F Ciampor; M Lukácová
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

10.  Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity.

Authors:  Carrie M Long; Paul A Beare; Diane C Cockrell; Jonathan Fintzi; Mahelat Tesfamariam; Carl I Shaia; Robert A Heinzen
Journal:  NPJ Vaccines       Date:  2021-03-19       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.